Rhythm Pharmaceuticals, Inc. (RYTM) Social Stream



Rhythm Pharmaceuticals, Inc. (RYTM): $3.41

0.14 (+4.28%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Rhythm Pharmaceuticals Inc (RYTM) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Rhythm Pharmaceuticals Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-03 3 $50 $17 $38 $11.78 222.58%
2021-11-19 3 $45 $15 $29.25 $11.78 148.3%
2021-12-01 4 $45 $15 $29.25 $11.78 148.3%
2021-12-08 5 $45 $15 $29.4 $11.78 149.58%
2022-01-26 5 $40 $10 $23.75 $11.78 101.61%
2022-02-07 5 $40 $10 $23 $11.78 95.25%
2022-02-17 5 $40 $12 $22.8 $11.78 93.55%
2022-02-28 5 $40 $10 $21.4 $11.78 81.66%
2022-03-01 5 $40 $9 $21.2 $11.78 79.97%
2022-03-02 6 $40 $9 $21.2 $11.78 79.97%
2022-03-03 6 $40 $9 $21.5 $11.78 82.51%

The Trend in the Analyst Price Target


RYTM's average price target has moved down $15.17 over the prior 165 days.

Over the past 47 weeks, RYTM's average upside potential has been 163.74%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-07-17 5 61 23 46.13 19.10 141.52%
2021-08-28 7 54 16 37.00 12.97 185.27%
2021-11-19 3 45 15 29.25 10.30 183.98%
2022-02-28 5 40 10 21.40 7.62 180.84%
2022-03-03 6 40 9 21.50 8.89 141.84%

RYTM Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.83 4 0 1 0 0 6

The Trend in the Broker Recommendations


RYTM's average broker recommendation rating worsened by 0.26 over the prior 24 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for RYTM as an investment opportunity.

  • Rhythm Pharmaceuticals Inc's variance in analysts' estimates is lower than -1132.05% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, Rhythm Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is higher than 1029.67% of them.
  • In terms of how Rhythm Pharmaceuticals Inc fares relative to Healthcare stocks, note that its number of analysts covering the stock is higher than 412.85% of that group.
  • Rhythm Pharmaceuticals Inc's average analyst price target is greater than 530.98% of Healthcare stocks.

In the Pharmaceutical Products industry, RXDX, RPTX, and RNA are the three stocks most similar to Rhythm Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.

Is RYTM a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6406 seconds.